The deal range was $12.87-$13.09. RBC Capital acted as sole book running manager for the offering.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CRMD:
- Closing Bell Movers: Nike gains 10% on more positive earnings call
- CorMedix announces $85M common stock offering
- CorMedix’s Promising Growth: Buy Rating Backed by Strong DefenCath Launch and Strategic Partnerships
- CorMedix Holds Annual Stockholders Meeting, Approves Key Proposals
- CorMedix Expands DefenCath Implementation with Major Client